MK-6204 (SKB535)

MK-6204 · Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-6204 (SKB535), covering 2025-03-13 to 2025-03-13. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of MK-6204 (SKB535) for Injection in Participants With Advanced Solid Tumors [Phase 1]

See pricing